VANTAGE CONSULTING GROUP INC Cyclo Therapeutics, Inc. Transaction History

VANTAGE CONSULTING GROUP INC portfolio value:

$266,000
portfolio value

VANTAGE CONSULTING GROUP INC quarter portfolio value change:

-33.27%
quarter

Cyclo Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +20.69% 6.25K shares -64K $7.28 36.51K
Q2 2022 share Decrease -0.64% -196 shares -13K $10.91 30.25K
Q1 2022 share Increase +0.44% 134 shares -37K $11.27 30.44K
Q4 2021 share Increase +4.77% 1.38K shares 22K $12.74 30.31K
Q3 2021 share Increase +28.13% 6.35K shares 51K $12.16 28.93K
Q2 2021 share Increase +33.84% 5.71K shares 82K $13.06 22.58K
Q1 2021 share Increase 0.00% 16.87K shares 225K $12.61 16.87K